SURMOUNT 2 principal investigator W. Timothy Garvey, MD, discusses data presented Friday at the Scientific Sessions on tirzepatide use for obesity and type 2 diabetes. Watch an on-demand recording of that symposium, SURMOUNT 2 Trial Results and Potential Role of Tirzepatide in Treating Obesity in Type 2 Diabetes, on the virtual platform at ADA2023.org.